Top Stock Losers
Explore the biggest stock losers today along with up-to-date performance data, including the latest price, share price changes, trading volume, and more. We cover the top stock losers and decliners every day with market data, news, and analysis from our Foolish experts.
Related Articles
Here's Why Relmada Therapeutics Stock Popped Today
Cory Renauer
|
Jul 27, 2021
Results from a human abuse potential study with REL-1017 exceeded expectations.
Why AquaBounty Technologies Stock Fell Hard Today
Jon Quast
|
Mar 24, 2021
Analysts say the charts are showing a "grim forecast" for this stock.
Why AquaBounty Technologies Stock Plunged Today
Evan Niu, CFA
|
Feb 4, 2021
The salmon producer prices a secondary offering as it raises fresh capital.
Here's Why AquaBounty Technologies Stock Went Up 14% in January
Jon Quast
|
Feb 2, 2021
The estimated cost for its new farm is rising, which kept the stock from going up more than it did last month.
Why AquaBounty Stock Was Falling Today After More Than Doubling in Two Weeks
Jon Quast
|
Dec 11, 2020
The company is raising cash to build its first large-scale salmon farm.
Is It Too Late to Buy These 3 Pharmaceutical Stocks?
James Halley
|
Jul 7, 2020
Relmada Therapeutics, Neoleukin Therapeutics, and Durect were among the fastest-rising pharmaceutical stocks over the past year.
Could Opioids Treat Depression? This Biotech Plans to Find Out
Zhiyuan Sun
|
May 19, 2020
Should investors be excited or concerned about Relmada Therapeutics' attempt to treat severe depression with a variant of methadone?
View More Articles